Medtronic Activa Medicare Coverage Decision Favored By Tech Assessment
This article was originally published in The Gray Sheet
Executive Summary
Clinical studies evaluating bilateral deep-brain stimulation (DBS) for treatment of Parkinson's disease support improved health outcomes associated with the procedure, a BlueCross BlueShield Association technology assessment suggests